Lucinda J Camidge

6PUBLICATIONS
32CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Environmental epidemiologyPredictive and prognostic markersSystems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 11, 2026
Real-world outcomes in patients with tumor-induced osteomalacia treated vs not treated with burosumab.

|Mar 13, 2025
Effectiveness of Switching from Multiple-Inhaler to Once-Daily Single-Inhaler Triple Therapy in Patients with COPD in a Real-World Setting in Japan.

Gema Requena, Lucinda J Camidge, Alexander Ford

|May 21, 2024
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study.

Kieran J Rothnie, Robert P Wood, Alexandrosz Czira

|Apr 02, 2024
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.

Afisi S Ismaila, Kieran J Rothnie, Robert P Wood

|Dec 13, 2023
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study.

Alexandrosz Czira, Shoko Akiyama, Takeo Ishii

|Sep 25, 2023
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.

Afisi S Ismaila, Kieran J Rothnie, Robert P Wood

Pageof 1

Frequent Collaborators

4 joint publications

Alexandrosz Czira

4 joint publications

Robert P Wood

4 joint publications

Kieran J Rothnie

4 joint publications

Afisi S Ismaila